Free Trial
OTCMKTS:GNGBY

Getinge (GNGBY) Stock Price, News & Analysis

Getinge logo
$27.90 -0.21 (-0.73%)
As of 11/13/2026 12:09 PM Eastern

About Getinge Stock (OTCMKTS:GNGBY)

Advanced

Key Stats

Today's Range
$27.90
▼
$27.90
50-Day Range
$23.93
▼
$28.70
52-Week Range
$18.99
▼
$28.83
Volume
338 shs
Average Volume
647 shs
Market Capitalization
$7.60 billion
P/E Ratio
25.36
Dividend Yield
1.00%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Getinge is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products.

The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing.

Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.

AI Generated. May Contain Errors.

Getinge Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

GNGBY MarketRank™: 
3.224980299445 of 5 stars

Getinge scored higher than 64% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Getinge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Getinge has only been the subject of 4 research reports in the past 90 days.

  • Read more about Getinge's stock forecast and price target.
  • Earnings Growth

    Earnings for Getinge are expected to grow by 8.09% in the coming year, from $1.36 to $1.47 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Getinge is 25.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Getinge is 25.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.

  • Price to Book Value per Share Ratio

    Getinge has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Getinge's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Getinge has been sold short.
  • Short Interest Ratio / Days to Cover

    Getinge has a short interest ratio ("days to cover") of 0.85, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Getinge pays a meaningful dividend of 1.03%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Getinge does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Getinge is 25.45%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Getinge will have a dividend payout ratio of 19.05% next year. This indicates that Getinge will be able to sustain or increase its dividend.

  • Read more about Getinge's dividend.
  • News Sentiment

    Getinge has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Getinge this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Getinge insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Getinge has minimal institutional ownership at this time.

  • Read more about Getinge's insider trading history.
Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNGBY Stock News Headlines

Getinge Establishes Sustainable Financing Framework
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
Getinge AB Earnings Call Signals Steady Margin Climb
Getinge Industrier AB ADR Stock Price History
See More Headlines

GNGBY Stock Analysis - Frequently Asked Questions

Getinge's stock was trading at $23.65 at the start of the year. Since then, GNGBY stock has increased by 18.0% and is now trading at $27.90.

Getinge (OTCMKTS:GNGBY) issued its quarterly earnings results on Wednesday, October, 21st. The company reported $0.32 earnings per share (EPS) for the quarter. The business had revenue of $875.58 million for the quarter. Getinge had a trailing twelve-month return on equity of 11.55% and a net margin of 8.20%.

Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
10/21/2026
Today
11/15/2026
Fiscal Year End
12/31/2026
Next Earnings (Estimated)
1/26/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
11,670
Year Founded
1904

Profitability

EPS (Trailing Twelve Months)
$1.10
Trailing P/E Ratio
25.36
Forward P/E Ratio
18.98
P/E Growth
N/A
Net Income
$230.87 million
Net Margins
8.20%
Pretax Margin
10.73%
Return on Equity
11.55%
Return on Assets
6.15%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
1.31
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$3.57 billion
Price / Sales
2.13
Cash Flow
$1.98 per share
Price / Cash Flow
14.06
Book Value
$11.07 per share
Price / Book
2.52

Miscellaneous

Outstanding Shares
272,370,000
Free Float
N/A
Market Cap
$7.60 billion
Optionable
Not Optionable
Beta
0.89

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (OTCMKTS:GNGBY) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners